An oncogenic role of Deleted in Liver Cancer 1 (DLC1) in metastatic melanoma

被引:0
|
作者
Yang, Xintao [1 ]
Cheung, May [1 ]
Lung, Hong-Lok [2 ]
Cheung, Martin [1 ]
机构
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Hong Kong Baptist Univ, Hong Kong, Peoples R China
关键词
D O I
10.1158/1538-7445.AM2018-99
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
99
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo
    Chan, Lo-Kong
    Ko, Frankie Chi Fat
    Sze, Karen Man-Fong
    Ng, Irene Oi-Lin
    Yam, Judy Wai Ping
    PLOS ONE, 2011, 6 (09):
  • [22] The transmembrane protein tetraspanin 5 controls the effects of loss of the tumor suppressor deleted in liver cancer 1 (DLC1) on hepatocellular carcinoma (HCC) growth
    Schreyer, L.
    Mittermeier, C.
    Martin, D. E.
    Singer, S.
    Liebl, B.
    Gudermann, T.
    Aigner, A.
    Muehlich, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S14 - S14
  • [23] The transcriptional coactivators Megakaryoblastic Leukemia 1/2 (MKL1/2) mediate tumorigenesis upon loss of the tumor suppressor Deleted in Liver Cancer 1 (DLC1)
    Hampl, V
    Khalid, S.
    Singer, S.
    Frank, N.
    Prywes, R.
    Gudermann, T.
    Muehlich, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 60 - 61
  • [24] Formation of the novel MKL1-Filamin A complex upon loss of the tumor suppressor deleted in liver cancer 1 (DLC1) promotes hepatocellular carcinoma growth
    Meier, M. A.
    Woerther, K.
    Hermanns, C.
    Gudermann, T.
    Muehlich, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S57 - S58
  • [25] DLC1 Interaction with α-Catenin Stabilizes Adherens Junctions and Enhances DLC1 Antioncogenic Activity
    Tripathi, Veenu
    Popescu, Nicholas C.
    Zimonjic, Drazen B.
    MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (11) : 2145 - 2159
  • [26] Endothelial DLC1 is dispensable for liver and kidney function in mice
    Tan, Ying
    Lo, Su Hao
    GENES & DISEASES, 2022, 9 (03) : 814 - 819
  • [27] Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)
    Li, Guorong
    Du, Xiaoli
    Vass, William C.
    Papageorge, Alex G.
    Lowy, Douglas R.
    Qian, Xiaolan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (41) : 17129 - 17134
  • [28] Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function
    Chan, Lo-Kong
    Ko, Frankie Chi Fat
    Ng, Irene Oi-Lin
    Yam, Judy Wai Ping
    PLOS ONE, 2009, 4 (05): : 1 - 11
  • [29] Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma
    Yang, Xintao
    Hu, Feng
    Liu, Jessica Aijia
    Yu, Shan
    Cheung, May Pui Lai
    Liu, Xuelai
    Ng, Irene Oi-Lin
    Guan, Xin-Yuan
    Wong, Kelvin K. W.
    Sharma, Rakesh
    Lung, Hong Lok
    Jiao, Yufei
    Lee, Leo Tsz On
    Cheung, Martin
    ONCOGENE, 2020, 39 (20) : 4061 - 4076
  • [30] Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma
    Xintao Yang
    Feng Hu
    Jessica Aijia Liu
    Shan Yu
    May Pui Lai Cheung
    Xuelai Liu
    Irene Oi-Lin Ng
    Xin-Yuan Guan
    Kelvin K. W. Wong
    Rakesh Sharma
    Hong Lok Lung
    Yufei Jiao
    Leo Tsz On Lee
    Martin Cheung
    Oncogene, 2020, 39 : 4061 - 4076